Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection? - Wikidata - awgldk - TriplyDB

Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?

Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?

http://www.wikidata.org/entity/Q30381104

about

Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?

http://www.wikidata.org/entity/Q30381104

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Does emerging Clarithromycin r ...... Helicobacter pylori infection?

@ast

Does emerging Clarithromycin r ...... Helicobacter pylori infection?

@en

type

label

Does emerging Clarithromycin r ...... Helicobacter pylori infection?

@ast

Does emerging Clarithromycin r ...... Helicobacter pylori infection?

@en

prefLabel

Does emerging Clarithromycin r ...... Helicobacter pylori infection?

@ast

Does emerging Clarithromycin r ...... Helicobacter pylori infection?

@en

P136

Q30381104-5E02EBBC-0019-4137-B79D-5C71C81D93C7

P1433

Q30381104-C7E8115F-6D97-406A-A31C-22C2F3709B8E

P1476

Q30381104-958375C7-B1EB-43FD-A36E-7B00A6785420

P2093

Q30381104-2E0C96D6-2E95-4DF8-80B0-5BE92633CC2B

Q30381104-57476D15-EB06-483C-ADE0-B6E6E6E709EB

Q30381104-692956A2-C1E6-48E0-9E09-B08E18D79088

Q30381104-88D20435-6918-4A3D-9AC8-CCC35E5C6E40

Q30381104-8E78FA87-7A12-41C0-95F4-411AA180827E

Q30381104-AC21D76A-2F94-4393-AFBA-668B284434EC

Q30381104-BF8B7F90-102C-45E7-AB90-CADD259331C0

Q30381104-CD4FED1E-D273-4085-AC70-98361DDD4E54

P2860

Q30381104-11ADA198-6D6F-4B5A-A93C-E7B4CA402CAB

Q30381104-2F721847-DCBD-47E7-ABD8-54410574D732

Q30381104-32990246-61B3-4284-A496-9E382D123475

Q30381104-3A8499C4-ABA1-4E18-98E3-28B87F289D1C

Q30381104-442EB01C-63D5-4AF7-8D25-E610FBB6BD6F

Q30381104-46C640CF-2051-47CD-A7E9-3BE6B8DB104E

Q30381104-49B63467-BC17-4543-805E-952736DC456A

Q30381104-4E9F0B8C-4B07-464C-8481-CEC1FA680454

Q30381104-5763880E-8B08-4FBD-AA11-D2A9611D0E83

Q30381104-6A127E38-AA0B-4A43-B7B0-18409B5BE923

P2888

Q30381104-0A1AFB53-0793-41B2-B6B6-66F7A3E86618

P304

Q30381104-14A96D80-E82F-4338-92BA-68A72CB11D2D

P31

Q30381104-BCB1EF65-99E6-44DE-B932-6B8E4C95EED6

P356

Q30381104-E7227E15-EB85-4E6A-98AD-B33C7DBCA7A3

P407

Q30381104-3E8E376E-BA7E-498D-91A6-A8833AFD71D6

P433

Q30381104-65FC829B-573A-41C5-BCC9-F35AE61A01B0

P478

Q30381104-7861C64B-F497-4332-83BD-8162A77EC45F

P577

Q30381104-A00D5A29-A101-4369-A3C6-CA80382F791D

P6179

Q30381104-904234E8-1F32-449D-B54F-FD3473450B05

P698

Q30381104-76D9AD28-1D8A-4874-9549-CE7992905997

P921

Q30381104-12F321C9-94FC-46E3-A220-246056C4AD84

P356

S12664-015-0604-1

P136

P1433

Indian Journal of Gastroenterology

P1476

Does emerging Clarithromycin r ...... Helicobacter pylori infection?

@en

P2093

Anil John

http://www.w3.org/2001/XMLSchema#string

Manik Sharma

http://www.w3.org/2001/XMLSchema#string

Moutaz Derbala

http://www.w3.org/2001/XMLSchema#string

Prem Chandra

http://www.w3.org/2001/XMLSchema#string

Rafie Yacoub

http://www.w3.org/2001/XMLSchema#string

Ragesh Babu

http://www.w3.org/2001/XMLSchema#string

Saad Al Kaabi

http://www.w3.org/2001/XMLSchema#string

Sanjay Doiphode

http://www.w3.org/2001/XMLSchema#string

P2860

Second and third line treatment options for Helicobacter pylori eradication

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.

Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?

Helicobacter pylori detection and antimicrobial susceptibility testing.

How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

Sequential therapy for Helicobacter pylori eradication: a critical review.

Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan.

P2888

s12664-015-0604-1

P304

404-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12664-015-0604-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1004609387

http://www.w3.org/2001/XMLSchema#string

P698

26541342

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori